Complete Response of Relapsed Systemic and Cutaneous Anaplastic Large Cell Lymphoma Using Brentuximab Vedotin: 2 Case Reports.

Complete Response of Relapsed Systemic and Cutaneous Anaplastic Large Cell Lymphoma Using Brentuximab Vedotin: 2 Case Reports.
Clin Lymphoma Myeloma Leuk. 2013 May 29;
Authors: Broccoli A, Derenzini E, Pellegrini C, Narducci R, Stefani G, Casadei B, Argnani L, Zinzani PL
PMID: 23726017 [PubMed - as supplied by publisher]

Source: Clinical Lymphoma and Myeloma - May 29, 2013 Category: Cancer & Oncology Authors: Broccoli A, Derenzini E, Pellegrini C, Narducci R, Stefani G, Casadei B, Argnani L, Zinzani PL Tags: Clin Lymphoma Myeloma Leuk Source Type: research